GSA CAPITAL PARTNERS LLP
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1362033
LONDON, X0
Position in KNSA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$542,024
-$2,303,978 QoQ
Shares Held
11,257
-83.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $10,107,066 across 16 Drug Manufacturers - Specialty & Generic names. KNSA ranks #8 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRWD |
Ironwood Pharmaceuticals Inc
|
654,445 | $2,297,101 | |
| 2 | LQDA |
Liquidia Corp
|
35,406 | $1,336,222 | |
| 3 | VTRS |
Viatris Inc
|
89,952 | $1,215,251 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
6,688 | $881,077 | |
| 5 | RGC |
Regencell Bioscience Holdings Ltd
|
31,569 | $802,799 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
101,438 | $588,340 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
10,556 | $545,639 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
11,257 | $542,024 |
All Filings in KNSA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $542,024 | 11,257 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,846,002 | 68,994 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,028,118 | 77,984 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $564,966 | 20,418 | Shares | Sole | 2025-07-22 | |
| 2024-09-30 | $268,117 | 10,729 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||